MedTrace Logo

GlucoFriend-evaluation the Effectiveness of Glucobay When Combined With a Basal Insulin

NCT01248481 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 539

Last updated 2013-06-20

No results posted yet for this study

Summary

To evaluate the effectiveness of Glucobay when combined with a basal insulin under daily-life treatment conditions in a large sample of Korean patients.

Conditions

Interventions

DRUG

Acarbose (Glucobay, BAYG5421)

Adult female and male patients are scheduled to be treated with acarbose will be enrolled after the therapy decision has been made. Physicians should consult the full prescribing information for Glucobay® before enrolling patients and familiarize themselves with the safety information in the product package label.

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Completion
2012-07-31

Countries

  • South Korea

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01248481 on ClinicalTrials.gov